phentermine or glp-1 TMates Under Review: Affordable GLP-1
Description
The future may involve: Sequencing and Combination: Using agents with complementary mechanisms (e.g., an incretin for weight loss combined with a myostatin inhibitor for lean mass preservation)
Journal of Clinical Pharmacology , 55(5), pp.497504
Still, we can also look at results from Wegovy clinical trials for weight loss to get a sense of how effective this drug might be for weight management
That compounded product is not the brand-name Wegovy pill sold now
Xtandis patent is expected to expire in 2027
